Vorinostat Combined with Third Generation Tkis to Overcome Egfr C797 Mutation in Lung Adenocarcinoma (III) = 利用Vorinostat與第三代酪胺酸激酶抑制劑聯合治療肺腺癌EGFR 點突變C797所造成的抗藥性 (III)